Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

The evolving diagnostic landscape of early phase trials

Challenges of HLA, neoantigen, and immune biomarker testing for early phase immunomodulatory therapy trials

Date

16 Sep 2024

Session

The evolving diagnostic landscape of early phase trials

Topics

Immunotherapy

Tumour Site

Presenters

Michal Bassani-Sternberg

Authors

M. Bassani-Sternberg

Author affiliations

  • Oncology Department, Ludwig Institute for Cancer Research, Lausanne - DOF - UNIL, CH-1066 - Lausanne/CH

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Presentation of case/condition

Presenter: Alexander Drilon

Session: The evolving diagnostic landscape of early phase trials

Resources:

Slides

Webcast

Q&A and discussion

Session: The evolving diagnostic landscape of early phase trials

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.